Optimizing Lung Cancer Radiation Therapy: A systematic review of Multifactorial Risk Assessment for Radiation-Induced Lung Toxicity

Lung cancer remains a global health challenge, accounting for over two million new cases annually and one of the highest mortality rates among all cancers in 2020 [1]. Non-small-cell lung cancer (NSCLC) represents approximately 80% of total cases. In 2010, between 15% and 25% of lung cancer patients presented with inoperable tumors at diagnosis, with concurrent chemoradiotherapy (CCRT) using platinum as the standard of care for this population facing a NSCLC or a small-cell lung cancer (SCLC); both taking benefit from this therapeutic [2,3].
Source: Cancer Treatment Reviews - Category: Cancer & Oncology Authors: Tags: Anti-tumour Treatment Source Type: research